These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30698289)

  • 21. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
    Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.
    Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N
    Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
    Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
    J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
    Anderson JE; Vargas C
    Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.
    Greco S; De Simone M; Colussi C; Zaccagnini G; Fasanaro P; Pescatori M; Cardani R; Perbellini R; Isaia E; Sale P; Meola G; Capogrossi MC; Gaetano C; Martelli F
    FASEB J; 2009 Oct; 23(10):3335-46. PubMed ID: 19528256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Satellite cells from dystrophic muscle retain regenerative capacity.
    Boldrin L; Zammit PS; Morgan JE
    Stem Cell Res; 2015 Jan; 14(1):20-9. PubMed ID: 25460248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Satellite Cells in Muscular Dystrophy - Lost in Polarity.
    Chang NC; Chevalier FP; Rudnicki MA
    Trends Mol Med; 2016 Jun; 22(6):479-496. PubMed ID: 27161598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.
    Villalta SA; Deng B; Rinaldi C; Wehling-Henricks M; Tidball JG
    J Immunol; 2011 Nov; 187(10):5419-28. PubMed ID: 22013114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice.
    Verma M; Asakura Y; Hirai H; Watanabe S; Tastad C; Fong GH; Ema M; Call JA; Lowe DA; Asakura A
    Hum Mol Genet; 2010 Nov; 19(21):4145-59. PubMed ID: 20705734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mineralocorticoid Receptor Antagonists in Muscular Dystrophy Mice During Aging and Exercise.
    Lowe J; Kadakia FK; Zins JG; Haupt M; Peczkowski KK; Rastogi N; Floyd KT; Gomez-Sanchez EP; Gomez-Sanchez CE; Elnakish MT; Rafael-Fortney JA; Janssen PML
    J Neuromuscul Dis; 2018; 5(3):295-306. PubMed ID: 30010143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice.
    Hindi SM; Shin J; Ogura Y; Li H; Kumar A
    PLoS One; 2013; 8(8):e72121. PubMed ID: 23977226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling.
    Acuña MJ; Pessina P; Olguin H; Cabrera D; Vio CP; Bader M; Muñoz-Canoves P; Santos RA; Cabello-Verrugio C; Brandan E
    Hum Mol Genet; 2014 Mar; 23(5):1237-49. PubMed ID: 24163134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.
    Villalta SA; Rinaldi C; Deng B; Liu G; Fedor B; Tidball JG
    Hum Mol Genet; 2011 Feb; 20(4):790-805. PubMed ID: 21118895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors.
    Cerquone Perpetuini A; Giuliani G; Reggio A; Cerretani M; Santoriello M; Stefanelli R; Palma A; Vumbaca S; Harper S; Castagnoli L; Bresciani A; Cesareni G
    Sci Rep; 2020 Mar; 10(1):5363. PubMed ID: 32210313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic background affects properties of satellite cells and mdx phenotypes.
    Fukada S; Morikawa D; Yamamoto Y; Yoshida T; Sumie N; Yamaguchi M; Ito T; Miyagoe-Suzuki Y; Takeda S; Tsujikawa K; Yamamoto H
    Am J Pathol; 2010 May; 176(5):2414-24. PubMed ID: 20304955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.
    Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG
    Hum Mol Genet; 2009 Feb; 18(3):482-96. PubMed ID: 18996917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
    Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
    Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Satellite cell-specific deletion of Cipc alleviates myopathy in mdx mice.
    Zheng J; Lou J; Li Y; Qian P; He W; Hao Y; Xue T; Li Y; Song YH
    Cell Rep; 2022 Jun; 39(11):110939. PubMed ID: 35705041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.